Notch receptor 1 (NOTCH1)

Notch receptor 1 (NOTCH1) is a single-pass type I transmembrane protein that serves as a key cell-surface receptor in the highly conserved Notch signaling pathway[2][7][9]. NOTCH1 is synthesized as a precursor protein, undergoes S1 cleavage in the Golgi apparatus, and is presented on the cell surface as a mature heterodimer consisting of a large extracellular domain and a membrane-associated transmembrane-intracellular domain[1][6][7]. The extracellular domain contains multiple epidermal growth factor (EGF)-like repeats for ligand binding, while the intracellular domain contains domains for nuclear translocation and transcriptional activation[1][5]. Activation occurs through ligand (Delta-like or Jagged) binding from neighboring cells, initiating site-specific proteolysis (by ADAM metalloproteases and γ-secretase) that releases the Notch intracellular domain (NICD), which translocates to the nucleus and modifies gene transcription via CSL (RBPJ) transcription factor complexes[2][8][6]. NOTCH1 signaling regulates cell fate decisions, cell cycle progression, proliferation, differentiation, and apoptosis during embryonic development and adult tissue homeostasis[2][4]. Dysregulation of NOTCH1 is implicated in a wide array of diseases including T cell leukemia/lymphoma, solid tumors, congenital cardiovascular disorders (such as bicuspid aortic valve, Alagille syndrome), and neurodegeneration[2][3][4][6][9]. The pathway is targeted pharmacologically in cancer and other diseases with γ-secretase inhibitors and anti-Notch antibodies, though toxicity stemming from pathway inhibition is a key challenge[6].

Other names

Neurogenic locus notch homolog protein 1Notch-1Notch proteinNOTCH1Neurogenic locus notch protein homolog 1

Inhibition of Notch cleavage and nuclear signaling, Blockade of Notch ligand binding, Antagonism of transcriptional complex formation